losclouds
Service profile

NuvalentNuvalent

Biopharmaceutical company developing brain-penetrant ROS1 and ALK inhibitors for treating non-small cell lung cancer and other solid tumors with kinase-driven mutations using structure-based drug design.

About

What Nuvalent is

Biopharmaceutical company developing brain-penetrant ROS1 and ALK inhibitors for treating non-small cell lung cancer and other solid tumors with kinase-driven mutations using structure-based drug design.

losclouds keeps public details for this profile. There are no catalog offerings to compare yet.

EnterpriseHealthcare

At a glance

Nuvalent service facts
FactValue
Official sitehttps://nuvalent.com
Status coveragePublic status page
Founded2017
HeadquartersCambridge, Massachusetts, United States
CategoriesEnterprise, Healthcare
Loading offerings...